These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1397669)

  • 1. Typhoid Vi: a less reactogenic vaccine.
    Cumberland NS; St Clair Roberts J; Arnold WS; Patel RK; Bowker CH
    J Int Med Res; 1992 Jun; 20(3):247-53. PubMed ID: 1397669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assay.
    Ahmadi H; Tabaraie B; Maleknia S; Shapouri R; Nejati M; Pour Mirza Gholi F; Hedayati M; Sadati M; Zahednia S; Sharifat Salmani A
    J Med Microbiol; 2013 Feb; 62(Pt 2):283-286. PubMed ID: 23105026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.
    Klugman KP; Gilbertson IT; Koornhof HJ; Robbins JB; Schneerson R; Schulz D; Cadoz M; Armand J
    Lancet; 1987 Nov; 2(8569):1165-9. PubMed ID: 2890805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea.
    Kim YR; Yoo JH; Hur JK; Kang JH; Shin WS; Kang MW
    J Korean Med Sci; 1995 Oct; 10(5):314-7. PubMed ID: 8750055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.
    Acharya IL; Lowe CU; Thapa R; Gurubacharya VL; Shrestha MB; Cadoz M; Schulz D; Armand J; Bryla DA; Trollfors B
    N Engl J Med; 1987 Oct; 317(18):1101-4. PubMed ID: 3657877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD; Robbins JB
    J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with Salmonella typhi Vi capsular polysaccharide vaccine.
    Hessel L; Debois H; Fletcher M; Dumas R
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):609-20. PubMed ID: 10534182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to the Vi capsule of Salmonella Typhi in the serum of typhoid patients and healthy control subjects from a typhoid endemic region.
    House D; Ho VA; Diep TS; Chinh NT; Bay PV; Vinh H; Duc M; Parry CM; Dougan G; White NJ; Farrar JJ; Hien TT; Wain J
    J Infect Dev Ctries; 2008 Aug; 2(4):308-12. PubMed ID: 19741294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
    Tacket CO; Losonsky G; Taylor DN; Baron LS; Kopecko D; Cryz S; Levine MM
    J Infect Dis; 1991 Apr; 163(4):901-4. PubMed ID: 2010645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral typhoid vaccine. Acambis/Berna.
    Witherell GW
    Curr Opin Investig Drugs; 2003 Aug; 4(8):1010-8. PubMed ID: 14508886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific and Cross-reactive Plasmablast Response in Humans after Primary and Secondary Immunization with Vi Capsular Polysaccharide Typhoid Vaccine.
    Pakkanen SH; Kantele JM; Rombo L; Kantele A
    Scand J Immunol; 2017 Oct; 86(4):207-215. PubMed ID: 28675263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with Vi typhoid capsular polysaccharide vaccine in the U.K.
    Arnold WS; Harcus AW; St Clair Roberts J; Ward AE
    J Infect; 1992 Jul; 25(1):63-6. PubMed ID: 1522324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine].
    Wang ZG; Zhou WZ; Shi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Feb; 18(1):26-9. PubMed ID: 9812477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH; Hong JJ; Choi ES; Lee JW; Park JH
    J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.
    Yang HH; Wu CG; Xie GZ; Gu QW; Wang BR; Wang LY; Wang HF; Ding ZS; Yang Y; Tan WS; Wang WY; Wang XC; Qin M; Wang JH; Tang HA; Jiang XM; Li YH; Wang ML; Zhang SL; Li GL
    Bull World Health Organ; 2001; 79(7):625-31. PubMed ID: 11477965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotypes of human vaccinal antibodies to the Vi capsular polysaccharide of Salmonella typhi.
    Brugier JC; Barra A; Schulz D; Preud'homme JL
    Int J Clin Lab Res; 1993; 23(1):38-41. PubMed ID: 8477090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.